Loading…
Biogen Pharmachem Industries (BSE 531752)₹0.28000.00%Other Financial Services
Biogen Pharmachem Industries is compared with the 10 closest in size in Other Financial Services (126 companies in the industry). It has a ROCE of 1.0% against a peer median of 0.5%. By market cap it is #7 of 11 in this set.
As of · Peer set: 10 closest in size in Other Financial Services
| Company | M-cap (₹ Cr) | P/E | ROCE % | ROE % | Debt / equity | Div. yield % | Sales (₹ Cr) | Net profit (₹ Cr) | Qtr sales growth % | Qtr profit growth % | Compare |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Supra Trends | 34 | — | −7.2 | −11.6 | 0.36 | 0.0 | 10 | −1 | 10.3 | — | vs BSE 531752 |
| Sumedha Fiscal Services | 34 | 11.8 | 4.0 | 2.6 | 0.00 | 2.4 | 110 | 2 | 13.4 | 13.7 | vs BSE 531752 |
| Real Touch Finance | 33 | 6.7 | 11.2 | 10.4 | 4.43 | 0.0 | 39 | 5 | 5.5 | −13.3 | vs BSE 531752 |
| Bridge Securities | 32 | 18.6 | 43.6 | 32.3 | 0.01 | 0.0 | 2 | 2 | — | — | vs BSE 531752 |
| MPIL Corporation | 31 | — | −21.7 | −28.2 | 0.31 | 0.1 | 0 | −3 | 0.0 | — | vs BSE 531752 |
| Munoth Financial Services | 30 | — | −7.1 | −10.7 | 0.05 | 0.0 | 0 | −1 | −100.0 | — | vs BSE 531752 |
| Biogen Pharmachem Industries | 29 | — | 1.0 | 0.9 | 0.00 | 0.0 | 3 | 1 | — | −84.2 | — |
| West Leisure Resorts | 27 | — | 0.5 | 0.3 | 0.00 | 0.1 | 1 | 0 | −91.4 | −88.2 | vs BSE 531752 |
| ISL Consulting | 27 | — | −17.1 | −17.1 | 0.00 | 0.0 | 19 | −2 | −39.8 | — | vs BSE 531752 |
| Bervin Investments & Leasing | 27 | — | −50.0 | −65.9 | 0.22 | 0.0 | 0 | −16 | — | 71.6 | vs BSE 531752 |
| Longspur International Ventures | 26 | 30.4 | 2.3 | 1.8 | 0.33 | 0.0 | 4 | 1 | 15.6 | −15.0 | vs BSE 531752 |
| Peer median | 30 | 15.2 | 0.5 | 0.3 | 0.05 | 0.0 | 3 | 0 | 2.8 | −14.2 |
Listed companies closest to Biogen Pharmachem Industries in Other Financial Services include Supra Trends, Sumedha Fiscal Services, Real Touch Finance, Bridge Securities, MPIL Corporation, Munoth Financial Services, West Leisure Resorts, ISL Consulting.
Supra Trends, with a market cap of ₹33.71 Cr.
Biogen Pharmachem Industries' return on capital employed is 1.0%, above the peer median of 0.5%.